Skip to main content

ARCA biopharma, Inc. (ABIO)

NASDAQ: ABIO · Delayed Price · USD
2.34
0.03 (1.30%)
At close: Dec 8, 2021 4:00 PM
2.33
-0.01 (-0.43%)
After-hours:Dec 8, 2021 4:19 PM EST
Market Cap33.72M
Revenue (ttm)n/a
Net Income (ttm)-18.77M
Shares Out14.41M
EPS (ttm)-1.49
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume245,878
Open2.31
Previous Close2.31
Day's Range2.30 - 2.39
52-Week Range2.17 - 5.50
Beta2.51
Analystsn/a
Price Targetn/a
Earnings DateNov 1, 2021

About ABIO

ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase 2 clinical trial for the treatment of diseases caused by ribonucleic acid viruses initially focusing on COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase 2 trial for the treatment of atrial ...

IndustryBiotechnology
CEOMichael Bristow
Employees11
Stock ExchangeNASDAQ
Ticker SymbolABIO
Full Company Profile

Financial Performance

Financial Statements

News

4 Top Penny Stocks To Buy For Under $5

Top penny stocks traders decided to buy today but are they worth the risk? The post 4 Top Penny Stocks To Buy For Under $5 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock...

Other symbols:OTLKPROGSPPI
6 days ago - PennyStocks

ARCA biopharma Announces Completion of Enrollment in Phase 2b ASPEN-COVID-19 Clinical Trial Evaluating rNAPc2 as a Po...

WESTMINSTER, Colo., Dec. 02, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing targeted therapies for cardiov...

6 days ago - GlobeNewsWire

ARCA biopharma to Present at the Q4 Virtual Investor Summit on November 17th

WESTMINSTER, Colo., Nov. 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

4 weeks ago - GlobeNewsWire

ARCA biopharma Announces Third Quarter 2021 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., Nov. 02, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

1 month ago - GlobeNewsWire

ARCA Biopharma Stock Gains As Safety Committee Recommends COVID-19 Trial To Continue Unchanged

The Data and Safety Monitoring Committee (DSMC) has completed a pre-specified interim analysis for ARCA biopharma Inc's (NASDAQ: ABIO) ASPEN-COVID-19 Phase 2b trial evaluating rNAPc2, a small recombinan...

1 month ago - Benzinga

ASPEN-COVID-19 Data and Safety Monitoring Committee Recommends Continuing Phase 2b Clinical Trial to Completion Based...

WESTMINSTER, Colo., Oct. 28, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

1 month ago - GlobeNewsWire

ARCA biopharma Announces Enrollment of First International Patient in Phase 2b Clinical Trial Evaluating rNAPc2 as a ...

WESTMINSTER, Colo., Sept. 16, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapie...

2 months ago - GlobeNewsWire

ARCA biopharma to Present at the Q3 Virtual Investor Summit on August 18th

WESTMINSTER, Colo., Aug. 16, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

3 months ago - GlobeNewsWire

ARCA biopharma Announces Second Quarter 2021 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., Aug. 04, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

4 months ago - GlobeNewsWire

ARCA biopharma Provides Update on ASPEN-COVID-19 Phase 2b Clinical Trial Evaluating rNAPc2 as a Potential Treatment f...

WESTMINSTER, Colo., July 13, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

4 months ago - GlobeNewsWire

ARCA biopharma to Present at Access to Giving Virtual Investor Conference on July 13th

WESTMINSTER, Colo., July 09, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

4 months ago - GlobeNewsWire

Best Reddit Penny Stocks to Buy Now? 7 for Your July Small-Caps List

Are these Reddit penny stocks the best 7 to watch in July 2021? The post Best Reddit Penny Stocks to Buy Now?

5 months ago - PennyStocks

ARCA biopharma Announces First Quarter 2021 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., May 11, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies ...

6 months ago - GlobeNewsWire

Christopher Graybill Joins ARCA as Vice President, Clinical Development

WESTMINSTER, Colo., May 05, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies ...

7 months ago - GlobeNewsWire

ARCA biopharma Announces C. Jeff Dekker to be Appointed Chief Financial Officer

WESTMINSTER, Colo., May 03, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies ...

7 months ago - GlobeNewsWire

ARCA biopharma Announces 2020 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., March 18, 2021 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapie...

8 months ago - GlobeNewsWire

3 Net-Net Working Capital Stocks

There are some investors who purchase stocks that are trading below their liquidation value because they believe they can make impressive gains out of their investments after the market has reassessed t...

Other symbols:ATHAMTCR
9 months ago - GuruFocus

ARCA biopharma Announces Location Change for 2020 Annual Meeting of Stockholders

WESTMINSTER, Colo., Dec. 09, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), today announced that its 2020 Annual Meeting of Stockholders, scheduled for Thursday, December 10, 2020 at 9:00...

11 months ago - GlobeNewsWire

AB201 Development as a Potential Treatment for COVID-19 Receives U.S. FDA Fast Track Designation

WESTMINSTER, Colo., Nov. 23, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

1 year ago - GlobeNewsWire

ARCA biopharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., Nov. 02, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

1 year ago - GlobeNewsWire

ARCA biopharma Announces FDA Approval of IND Application for AB201 as a Potential Treatment for COVID-19

WESTMINSTER, Colo., Oct. 07, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

1 year ago - GlobeNewsWire

ARCA biopharma Announces Promotion of Chief Medical Officer and Vice President, Regulatory Affairs & Quality

WESTMINSTER, Colo., Oct. 05, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies...

1 year ago - GlobeNewsWire

ARCA biopharma Announces Submission of IND Application to U.S. FDA for AB201 as a Potential Treatment for COVID-19

WESTMINSTER, Colo., Sept. 21, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therap...

1 year ago - GlobeNewsWire

Arca Biopharma Announces Second Quarter 2020 Financial Results and Provides Corporate Update

WESTMINSTER, Colo., Aug. 05, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapi...

1 year ago - GlobeNewsWire

ARCA biopharma Announces Closing of $6.1 Million Registered Direct Offering

WESTMINSTER, Colo., June 03, 2020 (GLOBE NEWSWIRE) -- ARCA biopharma, Inc. (Nasdaq: ABIO) a late stage biopharmaceutical company applying a precision medicine approach to developing genetically target...

1 year ago - GlobeNewsWire